| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |